Prospective real-world study for factors influencing the diagnostic quality and safety of hysterosalpingography with opium poppy ethyl iodine oil

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024149

Enrollment

Unknown

Registered

2019-06-27

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hysterosalpingography

Interventions

Case series:imaging diagnosis by opium poppy ethyl iodine oil

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Women aged 18 and above; 2. Accord with the indication of hysterosalpingography; 3. Understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: Complications or social environments that can cause subjects to fail to follow research plans or even endanger patient safety

Design outcomes

Primary

Measure	Time frame
Quality of image diagnosis ;safety;	—

Countries

China

Contacts

Public ContactOU HUA

YaHe Hospital for Woman & Children

OUHUA1022@163.COM+86 13381330008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026